Research & Development

Clinical Trials

Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma
https://clinicaltrials.gov/ct2/show/NCT05226494?term=NanoPharmaceuticals&draw=2&rank=1

If you would like to be considered to participate in the trial, please email Farah Fasihuddin at Yale Cancer Center: farah.fasihuddin@yale.edu